CONMED's shares receive 'hold' rating — 5 points

Spinal Tech

Zacks upgraded CONMED's shares to a 'hold' rating on Nov. 19, according to Dakota Financial News.

Here are five points:

 

1. Zacks stated CONMED's sales were negatively impacted by foreign exchange.

 

2. CONMED's shares traded up 0.84 percent to $42.17 on Nov. 19.

 

3. On Nov. 19, 15,771 shares were exchanged.

 

4. The company has a 12-month-low of $37.94 and a 12-month-high of $60.66.

 

5. Its 50-day moving average is $44.04 and its 200-day moving average is $52.43.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers